Cargando…

A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab

CONTEXT: Cutaneous adverse drug eruptions are the most common adverse reactions attributed to drugs in which any type of skin reaction can be mimicked, induced, or aggravated. AIMS: To study the pattern of various types of cutaneous adverse drug reactions (CADRs), to find out the causative drug(s) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jha, Niharika, Alexander, Emy, Kanish, Bimal, Badyal, Dinesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137653/
https://www.ncbi.nlm.nih.gov/pubmed/30258795
http://dx.doi.org/10.4103/idoj.IDOJ_81_18
_version_ 1783355213852180480
author Jha, Niharika
Alexander, Emy
Kanish, Bimal
Badyal, Dinesh K.
author_facet Jha, Niharika
Alexander, Emy
Kanish, Bimal
Badyal, Dinesh K.
author_sort Jha, Niharika
collection PubMed
description CONTEXT: Cutaneous adverse drug eruptions are the most common adverse reactions attributed to drugs in which any type of skin reaction can be mimicked, induced, or aggravated. AIMS: To study the pattern of various types of cutaneous adverse drug reactions (CADRs), to find out the causative drug(s) involved and to determine the response to treatment and outcome in patients with CADRs. PATIENTS AND METHODS: This prospective study was done in the department of dermatology. Patients with suspected drug rash, of either sex and all age groups were included in the study. STATISTICAL ANALYSIS: Frequencies and proportions were calculated using Chi-square test and t-test as the tests of significance. Data was analyzed using SPSS version 21. RESULTS: A total of 258 patients were enrolled in the study. The most common CADR observed in the study was exanthematous drug eruption in 42.63% patients followed by drug induced urticaria in 21.32% patients. Antimicrobials were the most common offending drugs in 64.73% of patients, followed by non-steroidal anti-inflammatory drugs (NSAIDs) in 15.50% patients. In the study, 12 patients (4.65%) were found to have severe cutaneous adverse drug reactions (SCADRs). Stevens–Johnson syndrome (SJS) - Toxic epidermal necrolysis (TEN) was the most common SCADR (50%) and antituberculous drugs were the most common causative group of drugs causing SCADRs. CONCLUSION: The most common CADR observed in the study was exanthematous drug eruption and antimicrobials were the most common causative drugs.
format Online
Article
Text
id pubmed-6137653
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-61376532018-09-26 A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab Jha, Niharika Alexander, Emy Kanish, Bimal Badyal, Dinesh K. Indian Dermatol Online J Original Article CONTEXT: Cutaneous adverse drug eruptions are the most common adverse reactions attributed to drugs in which any type of skin reaction can be mimicked, induced, or aggravated. AIMS: To study the pattern of various types of cutaneous adverse drug reactions (CADRs), to find out the causative drug(s) involved and to determine the response to treatment and outcome in patients with CADRs. PATIENTS AND METHODS: This prospective study was done in the department of dermatology. Patients with suspected drug rash, of either sex and all age groups were included in the study. STATISTICAL ANALYSIS: Frequencies and proportions were calculated using Chi-square test and t-test as the tests of significance. Data was analyzed using SPSS version 21. RESULTS: A total of 258 patients were enrolled in the study. The most common CADR observed in the study was exanthematous drug eruption in 42.63% patients followed by drug induced urticaria in 21.32% patients. Antimicrobials were the most common offending drugs in 64.73% of patients, followed by non-steroidal anti-inflammatory drugs (NSAIDs) in 15.50% patients. In the study, 12 patients (4.65%) were found to have severe cutaneous adverse drug reactions (SCADRs). Stevens–Johnson syndrome (SJS) - Toxic epidermal necrolysis (TEN) was the most common SCADR (50%) and antituberculous drugs were the most common causative group of drugs causing SCADRs. CONCLUSION: The most common CADR observed in the study was exanthematous drug eruption and antimicrobials were the most common causative drugs. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6137653/ /pubmed/30258795 http://dx.doi.org/10.4103/idoj.IDOJ_81_18 Text en Copyright: © 2018 Indian Dermatology Online Journal http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Jha, Niharika
Alexander, Emy
Kanish, Bimal
Badyal, Dinesh K.
A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab
title A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab
title_full A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab
title_fullStr A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab
title_full_unstemmed A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab
title_short A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab
title_sort study of cutaneous adverse drug reactions in a tertiary care center in punjab
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137653/
https://www.ncbi.nlm.nih.gov/pubmed/30258795
http://dx.doi.org/10.4103/idoj.IDOJ_81_18
work_keys_str_mv AT jhaniharika astudyofcutaneousadversedrugreactionsinatertiarycarecenterinpunjab
AT alexanderemy astudyofcutaneousadversedrugreactionsinatertiarycarecenterinpunjab
AT kanishbimal astudyofcutaneousadversedrugreactionsinatertiarycarecenterinpunjab
AT badyaldineshk astudyofcutaneousadversedrugreactionsinatertiarycarecenterinpunjab
AT jhaniharika studyofcutaneousadversedrugreactionsinatertiarycarecenterinpunjab
AT alexanderemy studyofcutaneousadversedrugreactionsinatertiarycarecenterinpunjab
AT kanishbimal studyofcutaneousadversedrugreactionsinatertiarycarecenterinpunjab
AT badyaldineshk studyofcutaneousadversedrugreactionsinatertiarycarecenterinpunjab